New Aetna Clinical Policy Bulletin Details ‘Medical Necessity’ Of Sarepta’s Exondys 51

After agreeing to cover Sarepta Therapeutics Inc SRPT 5.31%’s controversial Duchenne muscular dystrophy drug Exondys 51, insurer Aetna Inc AET 0.3% has released a new clinical policy bulletin describing the conditions under which it deems the drug medically necessary.

Aetna now says:

“[E]teplirsen (Exondys 51) injection is considered medically necessary for the treatment of individuals with a documented diagnosis of Duchenne muscular dystrophy (DMD) when the following criteria are met: 1) member has a confirmed mutation of the DMD gene amenable to exon 51 skipping; 2) eteplirsen has been initiated in childhood (before 14 years of age); 3) member is able to achieve an average distance of at least 180m while walking independently over six minutes; and 4) medication is prescribed by or in consultation with a physician who specializes in treatment of Duchenne muscular dystrophy.”

Aetna also clarified its position on the drug’s use outside of the conditions described above.

“Aetna considers eteplirsen (Exondys 51) injection experimental and investigational for all other indications.”

A number of the FDA’s internal reviewers of Exondys 51 expressed…

Click here to continue reading

Want to learn more about how to profit off the stock market? Or maybe you just want to be able to look sophisticated in front of your coworkers when they ask you what you are reading on your Kindle, and you’d prefer to tell them “Oh, I’m just reading a book about stock market analysis,” rather than the usual “Oh, I’m just looking at pics of my ex-girlfriend on Facebook.” For these reasons and more, check out my book, Beating Wall Street with Common SenseI don’t have a degree in finance; I have a degree in neuroscience. You don’t have to predict what stocks will do if you can predict what traders will do and be one step ahead of them. I made a 400% return in the stock market over five years using only basic principles of psychology and common sense. Beating Wall Street with Common Sense is now available on Amazon, and tradingcommonsense.com is always available on your local internet!